Vimarsana
Biggest News Aggregation in the World

Page 13 - Analytical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analytical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analytical Development Today - Breaking & Trending Today

Support scientific breakthroughs with MSD Carlow - hiring for various roles! - Vimarsana News

Support scientific breakthroughs with MSD Carlow - hiring for various roles!

MSD is a global network with endless opportunities MSD Carlow is a world-class manufacturing facility, focused on formulating and filling vaccines and biologics...

Between War and Peace: Implications of the Afghan Peace Deal - Vimarsana News

Between War and Peace: Implications of the Afghan Peace Deal

A discussion on the fragile trajectory of peace in Afghanistan and the Doha Agreement Peace Deal, hosted by the NATO Association of Canada. About this Event On April 22th, 2021, the NATO Association of Canada is proud to host a discussion on the fragile trajectory of peace in Afghanistan. Our experts Kathy Gannon and Kamran Bokhari will examine the implications of the Afghan peace deal on the country’s tense political landscape. Two veteran observers of the region, Kathy and Kamran will help us understand the complex, multi-faceted conflict that has ravaged the country for over a decade. Me...

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: New Investment in Tenaya Therapeutics - Vimarsana News

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: New Investment in Tenaya Therapeutics

RTW Leads $106 Million Financing Round in Tenaya Therapeutics RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Tenaya Therapeutics, Inc. ("Tenaya") on 01 March 2021 of its completion of a $106 million Series C financing round led by RTW Investments, LP (the "Investment Manager"). The Company, alongside other investment vehicles of the Investment Manager, confirms that it participated in the financing round...

Dresner Partners Advised JADE Biomedical (China) on Investment by and Partnership with Charles ... - Vimarsana News

Dresner Partners Advised JADE Biomedical (China) on Investment by and Partnership with Charles ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Dresner Partners Advised JADE Biomedical (China) on Investment by and Partnership with Charles ... Dresner PartnersFebruary 17, 2021 GMT SILICON VALLEY, Calif. and SHANGHAI, China, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised JADE Biomedical™ of China (JADE). Charles River Laboratories (CRL) has made an equity investment in JADE and formed a strategic business p...

Source: apnews.com
InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization - Vimarsana News

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization USA - English Share this article Share this article BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray ® Measles and Rubella (MR) antigen quantification kit.  Funded by the Bill and Melinda Gates Foundation with the goal of reducing the time and cost of manufacturing for these life-saving va...